Renal
CKD-Mineral Bone Disease (CKD-MBD)
KDIGO 2017 — assess Ca, phosphate, PTH, vitamin D, vascular calcification; phosphate binders, vitamin D analogues, calcimimetic, parathyroidectomy.
Source: KDIGO 2017 CKD-MBD
Step 1 of ~6
info
Monitor in CKD G3–G5
Check Ca, phosphate, PTH, alkaline phosphatase, 25-OH vitamin D from CKD G3 onwards. Frequency increases with declining GFR. Imaging: lateral lumbar XR for vascular calcification (annual in dialysis); echo for valvular calcification. DEXA for fracture risk in CKD G3.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Ergocalciferol with calcium lactate and calcium phosphate · Combined calcium + vitamin D
- Menadiol sodium phosphate · Water-soluble vitamin K analogue
- Pamidronate Disodium · IV Bisphosphonate (Paget's Disease / Bone Metastases / Hypercalcaemia)
- Phosphate · Phosphate replacement
- Amlodipine · Dihydropyridine Calcium Channel Blocker — Raynaud's / Peripheral Vascular Disease / Hypertension
- Hydroxocobalamin (High-Dose — Cyanide Antidote) · Cyanide Antidote (Vitamin B12 Precursor at High Dose)
Pathways
- Hyperkalaemia Management · UK Kidney Association Guidelines 2020; NICE CKD Guidelines
- Rhabdomyolysis · Renal Association 2018; UpToDate 2024
- Hypocalcaemia (Adult) · Society for Endocrinology
- SIADH (Endocrine Perspective) · European Hyponatraemia Guidelines 2014
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Acute Kidney Injury (AKI) · KDIGO 2012 / NICE AKI 2019
Decision support only. Always apply local guidelines and clinical judgement.